This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Alleviation of Hot Flashes With Increase in Venlafaxine Dose

Prasad R. Padala, MD; Srinivas B. Rapuri, MD; and Kalpana P. Padala, MD

Published: February 15, 2007

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Venlafaxine, a newer bicyclic antidepressant, acts as aserotonin-norepinephrine reuptake inhibitor (SNRI). Besidesimproving depressive symptoms, venlafaxine has also beendemonstrated to alleviate vasomotor symptoms.1 It is being increasinglyused as a nonhormonal drug to treat hot flashes,mostly in those women with concerns about or contraindicationsto estrogen-containing preparations.2

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 9

Quick Links: